-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) Misses Q1 EPS by 2c
-
-
-
-
-
-
-
Taysha's (TSHA) 'Moving into Registrational Studies, Shows Promise' - Citizens
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Taysha Gene Therapies (TSHA): Says it's Undervalued
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) Misses Q2 EPS by 1c
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) PT Raised to $6 at Citizens JMP
-
-
-
-
-
-
-
Truist: 'Expect Some Pressure On Dr. Marks' Resignation'
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) PT Lowered to $6 at Canaccord Genuity
-
446,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

